Stéphane is a Partner in Simon-Kucher’s global Healthcare & Life Sciences division and is based in the Boston office.
Since joining Simon-Kucher, he has advised both leading pharma and biotech companies in a variety of therapeutic areas including oncology, immunology, metabolic diseases, rare diseases, and vaccines.
Stéphane has focused on numerous strategic topics, including new product planning, competitive strategies, and pricing and market access across a product’s lifecycle. Through his work at Simon-Kucher supporting more than 25 pharma and biotech companies, he has developed an in-depth knowledge of the US health care system as well as other European and key global markets.
Prior to joining Simon-Kucher, Stéphane completed his PhD in Biological and Biomedical Sciences from Harvard University. He studied the deregulation of insulin signaling and cellular lipid metabolism in cancer.
Stéphane earned his BS in Biology from Massachusetts Institute of Technology, during which he studied the effects of calorie restriction on aging and cancer. He is an author on multiple peer-reviewed scientific publications and has extensive experience in biomedical research.
